Patient-Reported Outcomes

Anabolic Treatments for Osteoporosis

However, exciting new developments are on the verge of changing the treatment of this debilitating disorder. Two anabolic agents, the parathyroid hormone (PTH) and the fluoride ion, show tremendous promise as tools for building and retaining bone - with no adverse side effects.

This comprehensive account covers the latest studies on these two agents and provides a thorough assessment of their prospects as osteoporosis therapeutics. Combining basic science and up-to-date clinical data, it presents a complete picture of this breakthrough in the treatment of a globally significant health issue.